14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 MGNX stock ended at $16.05. This is 1.95% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 4.80% from a day low at $15.62 to a day high of $16.37.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
May 26, 2016 $24.31 $24.37 $23.88 $23.95 247 948
May 25, 2016 $23.80 $24.73 $23.55 $24.36 348 645
May 24, 2016 $22.96 $23.58 $22.67 $23.46 255 781
May 23, 2016 $22.49 $23.26 $22.36 $22.65 265 610
May 20, 2016 $21.47 $22.66 $21.47 $22.61 297 405
May 19, 2016 $20.88 $21.59 $20.55 $21.32 483 318
May 18, 2016 $19.99 $22.35 $19.84 $21.06 1 185 544
May 17, 2016 $18.18 $18.62 $17.78 $18.04 225 874
May 16, 2016 $17.56 $18.36 $17.00 $18.24 262 631
May 13, 2016 $16.76 $17.63 $16.28 $17.39 156 127
May 12, 2016 $17.80 $17.80 $16.50 $16.81 372 985
May 11, 2016 $18.58 $18.83 $17.52 $17.62 161 539
May 10, 2016 $18.79 $18.86 $17.87 $18.60 234 811
May 09, 2016 $18.18 $18.94 $18.16 $18.79 466 294
May 06, 2016 $18.62 $19.06 $18.08 $18.15 216 264
May 05, 2016 $18.46 $19.45 $16.77 $18.85 595 093
May 04, 2016 $19.78 $20.08 $19.42 $19.46 355 880
May 03, 2016 $20.49 $20.91 $19.84 $20.01 275 602
May 02, 2016 $20.53 $20.97 $19.70 $20.81 297 867
Apr 29, 2016 $20.67 $21.07 $20.18 $20.56 241 190
Apr 28, 2016 $20.92 $21.61 $20.44 $20.84 224 621
Apr 27, 2016 $21.26 $21.48 $20.68 $21.08 155 572
Apr 26, 2016 $21.97 $21.97 $21.04 $21.38 287 558
Apr 25, 2016 $22.21 $22.88 $21.89 $22.00 184 085
Apr 22, 2016 $21.77 $22.54 $21.23 $22.36 182 226
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT